PD-RISK Index: Piloting an unsupervised toolkit to identify adults with Parkinson disease
Output Details
Description
Effective screening for Parkinson disease (PD) is important for symptom management and
patient recruitment into disease-modifying trials. Here, we examined the performance of the
PD-RISK Index toolkit in identifying PD patients at home without supervision.
Between 2022-2024, we recruited 305 participants (ages, 40–85 years): 93 with typical PD;
66 had other neurological conditions; and 146 were healthy controls. Two versions of the
toolkit were completed: An original, 69-item-long questionnaire with the 40-scent
University-of-Pennsylvania-Smell-Identification-Test (UPSIT); thereafter, a simplified, 11-
item-short questionnaire with a newly-developed 8-scent smell test and responses submitted
online. The corresponding summary scores (‘PD-RISK Indices’) were calculated for each
subject to evaluate diagnostic performances.
In both versions, PD patients had higher questionnaire scores and worse olfaction than
healthy controls (*P<0.001*), as expected; scores for subjects with other neurological
conditions ranked at intermediate levels. The simplified 11-item questionnaire outperformed
the original version in identifying PD. The abbreviated 8-scent smell test and the UPSIT
booklet performed equally well in detecting hyposmia. The simplified PD-RISK Index
showed the highest diagnostic performance in identifying PD patients amongst all
participants; at a value of 23 (range, 0–100, where higher scores indicate higher PD risk), we
measured a sensitivity of 0.98, specificity of 0.83, and positive and negative likelihood ratios
of 5.88 and 0.02, respectively. The simplified ‘PD-RISK Index’ showed stable performance
across sexes and disease duration.
Our study reveals that unsupervised screening for manifest PD can be effectively carried out
at home using an 11-item questionnaire, 8-scent smell test and online data entry.
Identifier (DOI)
10.64898/2026.04.30.26352172